1. Trained Immunity for Personalized Cancer Immunotherapy: Current Knowledge and Future Opportunities
   Joana R. Lérias et al, 2020, Frontiers in Microbiology CrossRef
2. Structure-based Discovery of Narirutin as a Shikimate kinase Inhibitor with Anti-tubercular Potency
   Pramod Kumar Sahu et al, 2020, Current Computer-Aided Drug Design CrossRef
3. Strain-specific behavior of Mycobacterium tuberculosis in A549 lung cancer cell line
   Shima Hadifar et al, 2021, BMC Bioinformatics CrossRef
4. Is Mycobacterium tuberculosis carcinogenic to humans?
   Deodutta Roy et al, 2021, The FASEB Journal CrossRef
5. Pan-cancer analysis reveals NUP37 as a prognostic biomarker correlated with the immunosuppressive microenvironment in glioma
   Ya He et al, 2022, Aging CrossRef
6. Immunoenhancement effects of chitosan-modified ginseng stem-leaf saponins-encapsulated cubosomes as an ajuvant
   Tianxin Qiu et al, 2021, Colloids and Surfaces B: Biointerfaces CrossRef
7. Dark under the Lamp: Neglected Biological Pollutants in the Environment Are Closely Linked to Lung Cancer
   Dongjie Wang et al, 2024, International Journal of Molecular Sciences CrossRef
8. Lung cancer and pulmonary tuberculosis: key features of molecular mechanisms of concomitant disease
   G. M. Agafonov et al, 2024, Uspehi fiziologičeskih nauk CrossRef